oral disease in cats - PETS
Business Wire: Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease Reuters: FDA approves first oral treatment for cats with a type of diabetes FDA approves first oral treatment for cats with a type of diabetes Healthline: All about Oral Squamous Cell Carcinoma in People, Cats, and Dogs GREENFIELD, Ind.--(BUSINESS WIRE)--Today, Elanco Animal Health Incorporated (NYSE: ELAN) announced that the first shipments of Varenzin™-CA1 (molidustat oral suspension), conditionally approved by U.S ... Dec 8 (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved, opens new tab Elanco Animal Health Inc's (ELAN.N), opens new tab drug for cats with a type of diabetes, making it ...
Understanding the Context
The exact cause of oral squamous cell carcinoma is unknown. However, in people, smoking and drinking are major risk factors for developing this type of cancer. Heavy smokers who are also heavy ...